E-Folder
#1 in Business Subscribe Email Print

You are here: Home > Business > Strategic Planning > Strategic Management

Tags

  • managerial
  • vision
  • determining
  • companies involved
  • strategy formulation
  • strategy formulation

  • Links

  • Debt Options
  • Roast Beef Dinner Recipe
  • VoIP Resellership - A Safer Option
  • E-Folder - Strategic Management

    Strategic management is the process of specifying an organization's objectives, developing policies and plans to achieve these objectives, and allocating resources so as to implemen
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    t the plans. It is the highest level of managerial activity. It is not a task, but a rather a set of managerial skills that ought to be exerted throughout the organization, in a wi
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    e array of functions.

    An organization’s strategy must be appropriate for its resources, environmental circumstances, and core objectives. The process involves matching the company'
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    strategic advantages to the business environment the organization faces. One objective of an overall corporate strategy is to put the organization into a position to carry out its
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    ission effectively and efficiently.

    A good corporate strategy should integrate an organization’s goals, policies, and tactics into a cohesive whole, and must be based on business r
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    alities. Business enterprises can fail despite 'excellent' strategy because the world changes in a way they failed to understand. Strategy must connect with vision, purpose and like
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    y future trends.

    Strategic management can be seen as a combination of strategy formulation and strategy implementation, but strategy must be closely aligned with purpose.

    Strategy
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    formulation involves doing a situation analysis: both internal and external, both micro-environmental and macro-environmental; setting objectives—crafting vision statements (long t
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    rm view of a possible future), mission statements (the role that the organization gives itself in society), overall corporate objectives (both financial and strategic), strategic bu
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    iness unit objectives (both financial and strategic), and tactical objectives; and planning. This three-step strategy formulation process is sometimes described as determining wher
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    you are now, determining where you want to go, and then determining how to get there. These are the essence of strategic planning.

    Strategy implementation involves allocation of s
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    fficient resources (financial, personnel, time, technology support); establishing a chain of command or some alternative structure (such as cross functional teams); assigning respon
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    ibility of specific tasks or processes to specific individuals or groups; managing the process—monitoring results, comparing to benchmarks and best practices, evaluating the efficac
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    and efficiency of the process, controlling for variances, and making adjustments to the process as necessary. When implementing specific programs, this involves acquiring the requ
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    isite resources, developing the process, training, process testing, documentation, and integration with legacy processes.

    Strategy formulation and implementation is an on-going, ne
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    er-ending, integrated process requiring continuous reassessment and reformation. Strategic management is dynamic. It involves a complex pattern of actions and reactions. It is parti
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    lly planned and partially unplanned. Strategy is both planned and emergent, dynamic, and interactive.

    For strategic management to be a success, organizations must not fail to follo
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    the plan. They should be guided by the set of objectives that they have formulated, envisioning a prosperous business. They should strive to understand customers more thoroughly.
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    Over-estimation of resource competence and under-estimation of time requirements should be avoided. Employee and senior management commitment should be obtained through keeping co
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    munication channels open and healthy. Most crucially, the management should acquire the ability to predict environmental reaction and manage change.

    Copyright 2007 Ismael D. Tabij


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.e-folder.org.ua/article/44468/e-folder-Strategic-Management.html">Strategic Management</a>

    BB link (for phorums):
    [url=http://www.e-folder.org.ua/article/44468/e-folder-Strategic-Management.html]Strategic Management[/url]

    Related Articles:

    8 Questions To Ask Yourself Before Moving Into Management

    Outsourcing Bookkeeping Services

    Understanding Body Language: An Effective Sales Tool

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com